Evaluation of the interaction of loratadine and desloratadine with P-glycoprotein

Drug Metabolism and Disposition

Volumn 29, Issue 8, 2001, Pages 1080-1083

  Wang, Er Jia ^a   Casciano, Christopher N ^a   Clement, Robert P ^a   Johnson, William W ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; CYCLOSPORIN A; DAUNORUBICIN; DESLORATADINE; GLYCOPROTEIN P; LORATADINE; VERAPAMIL;

ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG HYDROLYSIS; DRUG PROTEIN BINDING; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IC 50; INTERMETHOD COMPARISON; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANTIBIOTICS, ANTINEOPLASTIC; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; DAUNORUBICIN; FLOW CYTOMETRY; HISTAMINE H1 ANTAGONISTS; HUMANS; HYDROLYSIS; KINETICS; LORATADINE; P-GLYCOPROTEIN; PHOSPHATES;

EID: 0034943050     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Relation between the turnover number for vinblastine transport and for vinblastine-stimulated ATP hydrolysis by human P-glycoprotein
2. Biochemical, cellular, and pharmacological aspects of the multidrug transporter
3. Desloratadine has no electrocardiographic or pharmacodynamic interactions with ketoconazole
4. Lack of interaction between desloratadine and erythromycin
5. Evaluation of the CNS properties of SCH 29851, a potent non-sedating antihistamine
6. 1-antagonist, loratadine
7. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine
8. A new polymorphism (N21D) in the exon 2 of the human MDR1 encoding the P-glycoprotein
9. Functional reconstitution of P-glycoprotein reveals an apparent near stoichiometric drug transport to ATP hydrolysis
10. Pharmacological considerations in the modulation of multidrug resistance
11. The influence of antihistamines on human performance
12. Biochemistry of multidrug resistance mediated by the multidrug transporter
13. P-glycoprotein and multidrug resistance
14. Functional polymorphism of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
15. Evaluation of desloratadine as a P-glycoprotein substrate using Caco-2 cells: Possible mechanisms and potential site of drug-drug interaction
16. Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance
17. P-glycoprotein gene (MDR1) cDNA from human adrenal: Normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance
18. Quantitative structure-activity relationship of multidrug resistance reversal agents
19. Structure-activity relationships of P-glycoprotein interacting drugs: Kinetic characterization of their effects on ATPase activity
20. Role of intestinal P-glycoprotein in interpatient variation in the oral bioavailability of cyclosporine
21. Genetic polymorphism in MDR-1: A tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors
22. Torsades de pointes occurring in association with terfenadine use
23. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole
24. Multiple-drug resistance in human cancer
25. Safety of second generation antihistamines
26. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: A double-blind comparison with crossover treatment of nonresponders
27. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving
28. Loratadine versus cetirizine: Assessment of somnolence and motivation during the workday
29. Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein
30. Characterization of the catalytic cycle of ATP hydrolysis by human P-glycoprotein: The two ATP hydrolysis events in a single catalytic cycle are kinetically similar but affect different functional outcomes
31. Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein
32. Ketoconazole effectively reverses multidrug resistance in highly resistant KB Cells
33. Second-generation antihistamines: A comparative review
34. Kinetics of the multidrug transporter (P-glycoprotein) and its reversal
35. Altered pharmacokinetics of vinblastine in mdr1a P-glycoprotein-deficient mice
36. In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein
37. Two transport binding sites of P-glycoprotein are unequal yet contingent: Initial rate kinetic analysis by ATP hydrolysis demonstrates intersite dependency
38. Cooperativity in the inhibition of P-glycoprotein-mediated daunorubicin transport: Evidence for half-of-the-sites reactivity